174 related articles for article (PubMed ID: 25501462)
1. Role of bone scan in the assessment of polymyositis/dermatomyositis.
An YS; Suh CH; Jung JY; Kim HA
Clin Rheumatol; 2015 Apr; 34(4):699-706. PubMed ID: 25501462
[TBL] [Abstract][Full Text] [Related]
2. Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation.
Tateyama M; Fujihara K; Misu T; Arai A; Kaneta T; Aoki M
BMJ Open; 2015 Jan; 5(1):e006763. PubMed ID: 25582454
[TBL] [Abstract][Full Text] [Related]
3. [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis.
Tanaka S; Ikeda K; Uchiyama K; Iwamoto T; Sanayama Y; Okubo A; Nakagomi D; Takahashi K; Yokota M; Suto A; Suzuki K; Nakajima H
Rheumatology (Oxford); 2013 Jul; 52(7):1271-8. PubMed ID: 23479721
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of dermatomyositis and polymyositis: a study of 102 cases.
Scola RH; Werneck LC; Prevedello DM; Toderke EL; Iwamoto FM
Arq Neuropsiquiatr; 2000 Sep; 58(3B):789-99. PubMed ID: 11018813
[TBL] [Abstract][Full Text] [Related]
5. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies.
Rider LG; Koziol D; Giannini EH; Jain MS; Smith MR; Whitney-Mahoney K; Feldman BM; Wright SJ; Lindsley CB; Pachman LM; Villalba ML; Lovell DJ; Bowyer SL; Plotz PH; Miller FW; Hicks JE
Arthritis Care Res (Hoboken); 2010 Apr; 62(4):465-72. PubMed ID: 20391500
[TBL] [Abstract][Full Text] [Related]
6. Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis.
Shimizu T; Tomita Y; Son K; Nishinarita S; Sawada S; Horie T
Clin Rheumatol; 2000; 19(5):352-9. PubMed ID: 11055823
[TBL] [Abstract][Full Text] [Related]
7. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients.
Sparsa A; Liozon E; Herrmann F; Ly K; Lebrun V; Soria P; Loustaud-Ratti V; Bouyssou-Gauthier ML; Boulinguez S; Bédane C; Jauberteau MO; Vidal E; Bonnetblanc JM
Arch Dermatol; 2002 Jul; 138(7):885-90. PubMed ID: 12071815
[TBL] [Abstract][Full Text] [Related]
8. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667
[TBL] [Abstract][Full Text] [Related]
9. Serum C1q Concentration Positively Correlates with Erythrocyte Sedimentation Rate in Polymyositis/Dermatomyositis.
Li L; Chen J; Chen S; Liu C; Zhang F; Li Y
Ann Clin Lab Sci; 2019 Mar; 49(2):237-241. PubMed ID: 31028070
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance imaging T
Zhang F; Xu J; Wang XX; Cheng YQ; Chen W
Zhonghua Nei Ke Za Zhi; 2024 Apr; 63(4):401-405. PubMed ID: 38561286
[TBL] [Abstract][Full Text] [Related]
11. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Aggarwal R; Rider LG; Ruperto N; Bayat N; Erman B; Feldman BM; Oddis CV; Amato AA; Chinoy H; Cooper RG; Dastmalchi M; Fiorentino D; Isenberg D; Katz JD; Mammen A; de Visser M; Ytterberg SR; Lundberg IE; Chung L; Danko K; García-De la Torre I; Song YW; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J;
Arthritis Rheumatol; 2017 May; 69(5):898-910. PubMed ID: 28382787
[TBL] [Abstract][Full Text] [Related]
12. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
13. Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis.
Son K; Tomita Y; Shimizu T; Nishinarita S; Sawada S; Horie T
Intern Med; 2000 Feb; 39(2):128-35. PubMed ID: 10732829
[TBL] [Abstract][Full Text] [Related]
14. Urinary levels of creatine and other metabolites in the assessment of polymyositis and dermatomyositis.
Chung YL; Wassif WS; Bell JD; Hurley M; Scott DL
Rheumatology (Oxford); 2003 Feb; 42(2):298-303. PubMed ID: 12595626
[TBL] [Abstract][Full Text] [Related]
15. T2 mapping in dermatomyositis/polymyositis and correlation with clinical parameters.
Ran J; Ji S; Morelli JN; Wu G; Li X
Clin Radiol; 2018 Dec; 73(12):1057.e13-1057.e18. PubMed ID: 30172348
[TBL] [Abstract][Full Text] [Related]
16. The role of MRI in the assessment of polymyositis and dermatomyositis.
Tomasová Studynková J; Charvát F; Jarosová K; Vencovsky J
Rheumatology (Oxford); 2007 Jul; 46(7):1174-9. PubMed ID: 17500079
[TBL] [Abstract][Full Text] [Related]
17. Serum muscle enzymes, muscle pathology and clinical muscle weakness: correlation in Thai patients with polymyositis/dermatomyositis.
Louthrenoo W; Weerayutwattana N; Lertprasertsuke N; Sukitawut W
J Med Assoc Thai; 2002 Jan; 85(1):26-32. PubMed ID: 12075717
[TBL] [Abstract][Full Text] [Related]
18.
Arai-Okuda H; Norikane T; Yamamoto Y; Mitamura K; Fujimoto K; Takami Y; Wakiya R; Nakashima S; Dobashi H; Nishiyama Y
Eur J Hybrid Imaging; 2020 Aug; 4(1):14. PubMed ID: 34191182
[TBL] [Abstract][Full Text] [Related]
19. Aldolase levels in dermatomyositis and polymyositis with normal creatine kinase levels.
Liozon E; Vidal E; Sparsa A
J Rheumatol; 2003 Sep; 30(9):2077-8; author repliies 2078. PubMed ID: 12966620
[No Abstract] [Full Text] [Related]
20. Serum levels of soluble ST2 and interleukin-33 in patients with dermatomyositis and polymyositis.
Yuan L; Yao L; Zhao L; Xia L; Shen H; Lu J
Clin Exp Rheumatol; 2013; 31(3):428-32. PubMed ID: 23485578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
